Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Biology|June 24, 2022
Impact of FLT3-ITD Insertion Length on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort StudyElizabeth M Corley, Moaath K Mustafa Ali, Hanan Alharthy, et al.
Frontiers in Oncology|April 4, 2022
Impact of IDH1 c.315C>T SNP on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort StudyElizabeth M Corley, Moaath K Mustafa Ali, Hanan Alharthy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2022
Phase I Clinical Trial of DNA Methyltransferase Inhibitor Decitabine and PARP Inhibitor Talazoparib Combination Therapy in Relapsed/Refractory Acute Myeloid LeukemiaMaria R Baer, Aksinija A Kogan, Søren M Bentzen, et al.
Leukemia Research|March 5, 2024
Clinical outcomes of patients with acute myeloid leukemia and cardiovascular diseaseGabriela Sanchez-Petitto, Olga G Goloubeva, Jack Masur, et al.
Acta Haematologica|August 27, 2024
Outcomes of Patients with Myeloid Malignancies and Cardiovascular Disease Undergoing Allogeneic Stem Cell TransplantationGabriela Sanchez-Petitto, Olga Goloubeva, James Childress, et al.
Leukemia|July 21, 2018
Heterogeneous expression of cytokines accounts for clinical diversity and refines prognostication in CMMLSandrine Niyongere, Nolwenn Lucas, Jun-Min Zhou, et al.
Blood|October 22, 2024
A phase 1 study of the amino acid modulator pegcrisantaspase and venetoclax for relapsed or refractory acute myeloid leukemiaYuchen Liu, Dominique R Bollino, Osman M Bah, et al.
Leukemia|November 17, 2020
Venetoclax and pegcrisantaspase for complex karyotype acute myeloid leukemiaAshkan Emadi, Bandish Kapadia, Dominique Bollino, et al.
Leukemia|March 22, 2019
Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemiaNolwenn Lucas, Matthieu Duchmann, Philippe Rameau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2021
Integrated Human and Murine Clinical Study Establishes Clinical Efficacy of Ruxolitinib in Chronic Myelomonocytic LeukemiaAnthony M Hunter, Hannah Newman, Amy E Dezern, et al.
Pageof 3